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Hepatic encephalopathy is potentially reversible, or progressive neuropsychiatric 
syndrome characterized by changes in cognitive function, behavior and personality 
changes, and transient neurologic symptoms and characteristic electroencephalographic 
patterns associated with acute and chronic liver failure. For some time, there has been 
controversy regarding the origin of toxins responsible for the change of mental state. It 
was found that the occurrence of hepatic encephalopathy is responsible for multiple 
organ peripheral changes (intestinal changes, abnormalities of portal-systemic circulation, 
liver failure, loss of muscle tissue), changes in brain intracellular communication (osmotic 
changes, astrocytes and axonal abnormalities in communication, changes in cerebral 
perfusion) and ammonia, endogenous benzodiazepines, gamma amino butyric acid, 
derivatives of methionine and false neurotransmitters. The aforementioned metabolic 
factors that contribute to the development of hepatic encephalopathy are not mutually 
exclusive and multiple factors may be present at the same time. Acta Medica Medianae 
2013;52(2):51-55. 
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Introduction 
 
 Hepatic  encephalopathy  (HE) is a potentially 
reversible, or progressive neuropsychiatric syndrome 
characterized by changes in cognitive function, 
behavior and personality changes, and transient 
neurologic symptoms and characteristic electro-
encephalographic patterns associated with acute 
and chronic liver failure (1, 2). 
Hepatic encephalopathy is a complication of 
cirrhosis, which is often viewed as part of severe 
liver failure. Characteristically, it occurs during 
development of acute encephalopathy with the 
slump awareness, manifesting as confusion or 
coma. Precipitating factor can often be identified. 
Treatment of this episode is directed to the 
correction of precipitating factor. Once the 
precipitating condition is resolved, encephalopathy 
also disappears, and the patient recovers to its 
previous state. However, in patients with low 
reserves of hepatic function, HE can become a 
chronic condition. Low reserve predisposes patients 
to spontaneous development of HE. Usually, there 
is a precipitating factor, so during the diagnosis 
and treatment, these aspects should be 
considered (3, 4). 
Acute HE is a disorder that often follows a 
fulminant hepatitis i.e. fulminant hepatic failure. 
It occurs most commonly during the first two to 
eight weeks from the onset of the disease 
(primarily referring to the signs of icterus, and 
other symptoms). By definition, fulminant hepatitis 
is always accompanied by HE (5). 
Chronic encephalopathy can be manifested 
as frequent episodes of acute encephalopathy 
(chronic recurrent encephalopathy) or permanent 
neurological manifestations (chronic persistent 
encephalopathy). Distinguishing between these 
two forms is rather subjective  and reflects in 
emphasizing neurological manifestations (6).   
 
The pathogenesis of hepatic encephalopathy 
 
For some time, there has been controversy 
regarding the origin of toxins responsible for the 
change of mental state. It is now certain that 
there are peripheral multiorgan changes, and 
changes in brain intracellular communication, due 
to changes in astrocytes. There has been debate 
about the role of ammonia, synergistic toxins, 
gamma aminobutyric acid (GABA) and endogenous 
benzodiazepines in the development of HE (4). 
 
Peripheral changes 
 
A. Intestinal 
 
There is controversy regarding the partici-
pation of Helicobacter pylori, which produces 
ammonia in the stomach, in the pathogenesis of 
hepatic encephalopathy. Some studies have shown 
a high prevalence of infection in patients with HE 
in alcoholic hepatitis, and in those with cirrhosis 
or chronic encephalopathy. However, eradication 
of H. pylori does not interfere with the levels of 
ammonia in this group of patients, and contribution 
to the development of HE is therefore minimal (7, 
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B. Portal-systemic communication 
 
It is shown that some congenital abnor-
malities that cause portal-systemic shunts are 
manifested in children by episodes of HE, even 
without pre-existing liver disease. Also, patients 
with cirrhosis and portal-systemic encephalopathy 
develop shunts easier than patients without shunts 
(2). 
  
C. Liver failure 
 
Many studies argue that the failure of the 
liver is the main cause of HE, resulting from the 
reduced functional capacity, which reduces the 
detoxification of ammonia, which leads to increasing 
its level in plasma and the resulting clinical 
manifestations of these patients’ functions. Degree 
of CNS damage correlates with the degree of 
liver damage (9). 
 
D. Muscle tissue 
 
Decreased muscle mass in cirrhotic patients 
may be a predisposition for the development of 
HE. Muscle loss cannot be explained only by the 
presence of liver disease and nutritional status of 
the patient, but also by increased levels of some 
cytokines such as tumor necrosis factor alpha 
(TNF-α), which activates the transcription factors 
NK-like, that further results in decreased synthesis 
of myosin. Consumption of muscle is associated 
with lower metabolic capacity of detoxification of 
ammonia and glutamine, and the formation of HE 
(10, 11). 
 
Brain changes 
 
A. Osmotic changes 
 
Some studies have shown that there are 
osmotic changes in patients with brain edema 
and liver dysfunction. On the one hand, brain 
edema develops increasing intracerebral pressure 
and can lead to incarceration and death (9). 
Glutamine produced for detoxification of ammonia 
in astrocytes is considered osmolar organic sub-
stance which can produce edema in astrocytes.   
It has been noted that a water channel aqua-
phorin-4 introduces water into the cell. There is 
evidence that the brain adapts to changes in 
chronic liver disease. Direct and indirect 
deterination of organic osmolars by reviewing 
resonance spectroscopy in humans showed a loss 
of mioinositol, taurine, and glyceryl-phosphocholin 
which are osmolars used by astrocytes in the 
regulation of intracellular osmolarity (3, 12, 13).
  
B. Axonal communication 
 
There is also evidence of the essential role 
of astrocytes in maintaining normal function of 
neurons. Alzheimer type 2 cells (astrocytes) may 
show some abnormalities: reduced activity of the 
neurotransmitter (glutamate), increased expression 
of benzodiazepine receptors and increased activity 
of monoamine oxidase (MAO). As a result, there 
are changes in metabolic communication between 
astrocyts and other cells. For example, astrocytes 
synthesize neurosteroids that activate GABA recep-
tors and endogenous benzodiazepine receptors. 
The brain does not create cycles of urea and 
ammonia is removed by glutamine synthetase in 
the reaction of ammonia with glutamate produ-
cing glutamine. With excess ammonia, logically, 
there is an excess of glutamine (3, 13). 
 
C. Brain blood flow and endothelial communi-
cation with astrocytes 
 
Patients with HE have fluctuations in cerebral 
perfusion. Some experimental models have shown 
increased cerebral perfusion in the presence of 
high levels of ammonia. There can be activated 
signals generated after the intracerebral glutamine 
synthesis in astrocyts. Hypothermia and cerebral 
edema play an important role in the development 
of low cerebral perfusion. Cirrhotic patients have 
decreased blood flow to the brain, probably due 
to peripheral vasodilatation. These changes may 
be the cause of decreased metabolic activity (3, 
13). 
 
D. Other hypotheses: 
 
- Ammonia 
 
Ammonia is a basic element in the 
pathogenesis of HE. Following the detoxification 
of ammonia by astrocytes, some neurochemical 
changes occur. There are many factors that interact 
with ammonia, including changes in astrocytes 
(hyponatremia, elevated cytokines, changes in 
ligand astrocytes), and produce anatomically and 
neurochemically substrate synergism which 
increases the possibility for the occurrence of HE. 
However, ammonia levels do not correlate with 
the severity of encephalopathy. The level of 
glutamine and alpha-ketoglutarate in cerebrospinal 
fluid correlate with the degree of HE. Basic 
mechanisms of action of ammonia are as follows: 
direct effect - the cell membrane of neurons 
(inhibition of Na
+ and K
+ ATP-ase) or post-
synaptic inhibition (blocking chloride pump) and 
an indirect effect – disruption of glutamatic neuro-
transmission impairs the function of neurons 
(glutamate is the major excitatory neurotrans-
mitter) (14). 
The main source of ammonia is the 
intestinal tract. It is created under the action of 
bacterial proteases, urease and amino oxidase to 
the intestinal contents, and by hydrolysis of 
glutamine. Under normal circumstances, most of 
the ammonia enters the port bloodstream to the 
liver portal tracts, metabolized in hepatocytes, 
and it remains a bit in the systemic circulation. 
However, when the majority of hepatocytes are 
destroyed or dysfunctional (fulminant hepatitis 
and other liver diseases), ammonia from the 
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bolized, and passes through the systemic circu-
lation to the CNS (14).   
Turbidity neurotransmission in elevated 
concentration of ammonia is associated with a 
decrease. Ammonia intoxication leads to hyperkinetic 
preconvulsive state, which does not correspond 
to HE and increases neural inhibition rather than 
excitation (14). 
 
- Endogenous benzodiazepines and GABA 
 
The role of these substances in the GABA-
mediated change (GABA-ergic neurotransmission) 
is not well understood. Some studies on 
flumazenil did not yield significant results; also, 
ammonia may activate the GABA-ergic pathways 
in the synthesis of neurosteroids astrocyts, as 
already mentioned (10). 
Gamma-aminobutyric acid is the major 
inhibitor of neurotransmission. It is synthesized 
from glutamate by glutamate dehydrogenase in 
presynaptic neurons and reversed in vesicles. 
Release of GABA neurons synapse cracks is 
associated with the specific GABA receptors in 
the postsynaptic membrane. This receptor is also 
part of a larger receptor complex, important for 
the binding of benzodiazepines and barbiturates. 
By binding of either GABA or benzodiazepine a 
channel for chloride opens, and their influx 
hyperstimulates the postsynaptic membrane and 
neuroinhibition occurs. Thus, the increase in 
GABA-mediated neurotransmission, followed by a 
decrease in motor function and consciousness, 
are the two cardinal manifestations of HE (10). 
Gamma-aminobutyric acid is synthesized 
by bacteria in the intestines through the portal 
vein and reaches the liver, where it metabolizes. 
In liver disease and portal-systemic shunts, 
GABA passes through the systemic circulation 
nonmetabolized. However, as is the case with 
ammonia, GABA levels in the serum and the 
degree of HE did not always correlate, even 
though the research focused on the afore-
mentioned receptor complex indicate the corre-
lation of benzodiazepines on activity in plasma 
and severity of HE (10).   
 
 -  Derivatives of methionine 
 
Mercaptans, derivatives of the intestinal 
metabolism of methionine, were thought to be 
caused by HE. The recent studies on metanefiol, 
a highly toxic mercaptan, have not indicated its 
involvement in the pathogenesis of HE (15).   
 
- False neurotransmitters 
 
Brain neurotransmission is normally carried 
out by means of dopamine and catecholamines, 
and may be inhibited by amines. These amines 
are produced by the effect of the bacteria from 
the column or by altered cerebral metabolism 
precursors (15). 
Decline in the level of branched-chain 
amino acids (valine, leucine, isoleucine; drop occurs 
due to increase in their metabolism outside the 
liver) may favor the entry of aromatic amino 
acids (tyrosine, phenylalanine, tryptophan, resul-
ting in impaired liver dissemination) in the brain, 
which are precursors of false neurotransmitters, 
which render the waste unrecognizable synthesis 
of glutamine. Aromatic amino acids easily undergo 
a modified blood-brain barrier in the altered 
balance of their concentration. The increase in 
levels of phenylalanine in the brain inhibits the 
production of dopamine, and the creation of false 
neurotransmitters such as octopamine and phenyl-
ethanolamine. Clinical experience with the branched-
chain amino acids is of great importance because 
it is possible that amino acids have a direct effect 
in the muscles, increasing the detoxification of 
ammonia. Other routes of transmission may be 
involved in the HE: serotonin (5-hydroxitryptamin, 
5-HT), opioids and catecholamines. Serotonin is 
represented in the control of cortical wake cycles 
and sleep / wakefulness, and the general state of 
mind. Serotonin is formed from tryptophan, a 
precursor tryptophan is an aromatic amino acid 
whose level increases in plasma, CSF and brain 
of patients with HE, and there is a possibility of 
increased synthesis of serotonin in HE (7). 
Other additional factors that favor the 
occurrence of recurrent episodes of HE are the 
nutritional status, particularly in alcoholics, who 
have a deficiency of vitamins and micronutrients. 
One such example is zinc deficiency, which is a 
cofactor in the urea cycle. Zinc supplementation, 
using a dose of 600 mg per day, is considered in 
the encephalopathy but showed no additional 
benefit. However, it seems reasonable to measure 
plasma levels of zinc and zinc supplements added 
when levels are low. The issue of colonization of 
the stomach with H. pylori, an organism that 
produces urease, has been recently discussed. 
Eradication of H. pylori may be useful in other 
diseases, but not associated with lower levels of 
ammonia or improvement in HE (7). Hepatic 
encephalopathy is the result of a combination of 
hepatic dysfunction (hepatic insufficiency), accumu-
lation of toxins and the establishment of portal-
systemic shunt. The main precipitating factor 
(that is not a specific cause) has changed the 
level of plasmatic ammonia. Pathogenetic mechanism 
involves the production of false neurotrans-
mitters, facilitated sensitivity of neurons by 
gamma aminobutyric acid (GABA), increased 
plasma levels of endogenous benzodiazepines, 
decreased activity of enzymes of urea cycle as a 
consequence of zinc deficiency, and finally, 
deposition of manganese in the basal ganglia (15). 
If the cause of fulminant hepatitis is HE, 
then all its associated conditions and complications 
(cerebral edema, coagulopathy, hypoglycemia, 
electrolyte and acid-base disorders, renal failure, 
hemodynamic changes, respiratory complications, 
acute pancreatitis, infection) are important factors 
in the development of HE (15, 16). 
 
Conclusion 
 
The aforementioned metabolic factors that 
contribute to the development of hepatic 
encephalopathy are not mutually exclusive and 
multiple factors may exist at the same time. Recent theories of pathogenesis of hepatic encephalopathy...                                                           Lidija Popović Dragonjić et al. 
54 
 
 
 
      References 
 
1.  Alturi DK, Prakash R, Mullen KD. Pathogenesis, 
diagnosis, and treatment of hepatic encephalopathy. 
Journal of Clinical and Experimental Hepatology 
2011; 1(2): 77-86. [CrossRef]  
2.  Ferenci P, Lockwood A, Mullen K, Tarter R, 
Weissenborn K, Blei AT.  Hepatic encephalopathy--
definition, nomenclature, diagnosis, and quantifi 
cation: final report of the working party at the 11th 
World Congresses of Gastroenterology, Vienna, 
1998.  Hepatology 2002; 35(3): 716-21.  [CrossRef] 
[PubMed] 
3.  Butterworth RF. Pathogenesis of hepatic encephalo 
pathy: new insights from neuroimaging and molecular 
studies.  J Hepatol  2003; 39(2): 278-85.  [CrossRef] 
[PubMed] 
4.  Blei AT, Córdoba J.  Hepatic Encephalopathy.  Am J 
Gastroenterol 2001; 96(7): 1968-76. [CrossRef] 
[PubMed] 
5.  Bokemeyer M, Ding X-Q, Goldbecker A, Raab P, 
Heeren M, Arvanitis D, et al. Evidence for neuro 
inflammation and neuroprotection in HCV infection-
associated encephalopathy. Gut 2011; 60(3): 370-
7. [CrossRef] [PubMed] 
6.  Sanchez-Munoz D, Pineda JA, Diaz F, Giron JA, 
Montero JL, de la Torre J, et al. Hepatic encephalo 
pathy is more frequent, severe and shortens the 
survival in HCV/HIV-related cirrhosis. Journal of 
Hepatology 2005; 42(Suppl 2): 85-6. [CrossRef]  
7.  Cordoba J, Lopez-Hellin J, Planas M, Sabín P, 
Sanpedro F, Castro F, et al. Normal protein diet for 
episodic hepatic encephalopathy: results of a 
randomized study. J Hepatol 2004; 41(1): 38-
43. [CrossRef] [PubMed] 
8.  Dasani B, Sigal S, Lieber C. Analysis of risk factors 
for chronic hepatic encephalopathy: the role of 
Helicobacter pylori infection. Am J Gastroenterol 
1998; 93(5): 726-31. [CrossRef] [PubMed] 
9.  Bernal W, Hall C, Karvellas CJ, Auzinger G, Sizer E, 
Wendon J. Arterial ammonia and clinical risk factors 
for encephalopathy and intracranial hypertension in 
acute liver failure. Hepatology 2007; 46(6): 1844-
52. [CrossRef] [PubMed] 
10. Goral V, Atayan Y, Kaplan A. The relation between 
pathogenesis of liver cirrhosis, hepatic encephalo 
pathy and serum cytokine levels: what is the role of 
tumor necrosis factor alpha? Hepatogastroentero 
logy 2011; 58(107-108): 943-8. [PubMed] 
11. Odeh M. Pathogenesis of hepatic encephalopathy: 
the tumour necrosis factor-alpha theory. Eur J Clin 
Invest 2007; 37(4): 291-304. [CrossRef] [PubMed] 
12. Blei AT. Brain edema in acute liver failure. Crit Care 
Clin 2008; 24(1): 99-114. [CrossRef] [PubMed] 
13. Brusilow SW, Koehler RC, Traystman RJ, Cooper AJ. 
Astrocyte glutamine synthetase:importance in hyper 
ammonemic syndromes and potential target for 
therapy. Neurother 2010; 7(4):452-70. [CrossRef] 
[PubMed] 
14. Brusilow SW.   Hyperammonemic encephalopathy.   
Medicine (Baltimore) 2002; 81(3): 240-9. [CrossRef] 
[PubMed] 
15. Lizardi-Cervera J, Almeda P, Guevara L, Uribe M. 
Hepatic encephalopathy: a review. Ann Hepatol 
2003; 2(3): 122-130. [PubMed] 
16. Riggio O, Efrati C, Catalano C, et al. High 
prevalence of spontaneous portal-systemic shunts in 
persistent hepatic encephalopathy: a case-control 
study.  Hepatology 2005; 42(5): 1158-65.  [CrossRef] 
[PubMed] 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 Acta Medica Medianae 2013, Vol.52(2)                                               Recent theories of pathogenesis of hepatic encephalopathy... 
  This work is licensed under a Creative Commons Attribution 4.0 International (CC BY 4.0) Licence.    55 
 
 
 
 
NOVIJE TEORIJE PATOGENEZE HEPATIČNE ENCEFALOPATIJE KOD 
VIRUSNE INFEKCIJE IZAZVANE HEPATITISOM C 
 
Lidija Popović Dragonjić, Dane Krtinić, Ivan Dragonjić 
 
 
Hepatička encefalopatija je potencijalno reverzibilan ili progresivan, neuropsihi-
jatrijski sindrom okarakterisan promenama u kognitivnoj funkciji, izmeni ponašanja i 
ličnosti, kao i prolaznim neurološkim simptomima i karakterističnim elektroencefalografskim 
šemama, udruženim sa akutnom i hroničnom insuficijencijom jetre. Već duže vreme 
postoje kontroverze u vezi sa poreklom toksina odgovornog za izmenu mentalnog stanja. 
Danas je utvrđeno da su za nastanak hepatičke encefalopatije odgovorne periferne 
multiorganske izmene (intestinalne promene, abnormalnosti portno-sistemske cirkulacije, 
insuficijencija jetre, gubitak mišićnog tkiva), izmene u moždanoj intracelularnoj 
komunikaciji (osmotske promene, abnormalnosti astrocita i aksonske komunikacije, 
promene moždane perfuzije), kao i amonijak, endogeni benzodiazepini, gama amino 
buterna kiselina, derivati metionina  i lažni neurotransmiteri. Pomenuti metabolički faktori 
koji doprinose nastanku hepatičke encefalopatije međusobno se ne isključuju, a multipli 
faktori mogu postojati u isto vreme.Acta Medica Medianae 2013;52(2):51-55. 
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